Antony C. Mattessich
OCULAntony C. Mattessich serves as President and CEO at Ocular Therapeutix, Inc. (OCUL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Antony C. Mattessich's Insider Trading at Ocular Therapeutix, Inc. (OCUL)
Buys
2 · $74.2K
Sells
3 · $269.6K
Total Shares Bought
11,500
Total Shares Sold
57,649
Related Insiders
Peter Kaiser
officer: Chief Development Officer
OCULSell · Feb 25, 2026
Pravin Dugel
See Remarks
OCULSell · Feb 25, 2026
Jeffrey S. Heier
officer: Chief Scientific Officer
OCULSell · Feb 25, 2026
Sanjay Nayak
officer: Chief Strategy Officer
OCULSell · Feb 25, 2026
Nadia Waheed
Chief Medical Officer
OCULSell · Feb 12, 2026
Donald Notman
See Remarks
OCULSell · Feb 12, 2026
Namrata Saroj
Chief Business Officer
OCULSell · Nov 7, 2025
Todd Anderman
Chief Legal Officer
OCULSell · Oct 10, 2025